Company profile: Viamet Pharmaceuticals
1.1 - Company Overview
Company description
- Provider of small molecule inhibitors of validated metalloenzymes developed via a proprietary metal-binding approach (Metallophile Technology) for the treatment of various diseases.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Viamet Pharmaceuticals
BioHelix
HQ: United States
Website
- Description: Provider of simple molecular diagnostic tests for the near patient setting, developed to improve the quality of healthcare.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioHelix company profile →
Micronics
HQ: United States
Website
- Description: Provider of near-patient in vitro diagnostic products for disease diagnosis, prognosis, and treatment monitoring in the United States and internationally, including the PanNAT molecular diagnostic system, a point-of-care testing instrument.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Micronics company profile →
Pattern Bioscience
HQ: United States
Website
- Description: Provider of biotech diagnostic solutions to combat antibiotic resistance, including Digital Culture Technology, a single-cell analysis platform using digital cell reactors and machine learning to rapidly diagnose complex bacterial infections and determine antibiotic response without traditional culture, and the Pneumonia Action Panel for fast, comprehensive pathogen identification and susceptibility in hospitalized severe pneumonia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pattern Bioscience company profile →
Cavidi
HQ: Sweden
Website
- Description: Provider of HIV viral load monitoring diagnostics and BOLD-based immunoassay signal amplification solutions, including Exazym reagent kits for attomole-level biomarker detection (up to 100x amplification), ClickChem conjugation, polymerase reaction and biotin detection kits, plus research services and collaborations on low-abundance biomarker discovery and immunoassay development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cavidi company profile →
Bioquell
HQ: United Kingdom
Website
- Description: Provider of biodecontamination systems and services specializing in Hydrogen Peroxide Vapor technology to eliminate bacteria, viruses, fungi, and spores. Products include Bioquell Hydrogen Peroxide Vapour Decontamination (35% H2O2 vapor for surface and airborne pathogen elimination), Rapid Bio-Decontamination Service, ProteQ automated room decontamination, and Qube isolators for sterility testing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bioquell company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Viamet Pharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Viamet Pharmaceuticals
2.2 - Growth funds investing in similar companies to Viamet Pharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Viamet Pharmaceuticals
4.2 - Public trading comparable groups for Viamet Pharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →